Showing 654 results

Filters Content type: News, Editors' picks, About HIV Topic: New & experimental hepatitis C treatment

News and information about clinical trials and regulatory approval of new medications to treat hepatitis C.

New & experimental hepatitis C treatment

Achillion's hepatitis C drug gets FDA fast track

Editor's pick
Reuters
16 May 2012
New & experimental hepatitis C treatment

BI 201335 & BI 207127 and ribavirin shows good efficacy, including hepatitis C patients with cirrhosis

News
15 May 2012
Hepatitis C treatment

Ribavirin dose reduction is effective for managing anaemia in patients using boceprevir or telaprevir

News
11 May 2012
New & experimental hepatitis C treatment

Promising findings for therapeutic hepatitis C vaccine TG4040

News
9 May 2012
New & experimental hepatitis C treatment

New Drugs Require New Terms for HCV Virologic Response

Editor's pick
Medscape (requires registration)
9 May 2012
New & experimental hepatitis C treatment

Aethlon Medical Reports Undetectable Hepatitis C Virus (HCV) in Genotype 1, Genotype 3, and Genotype 5 Patients Treated with Hemopurifier® Therapy

Editor's pick
MarketWatch (press release)
8 May 2012
New & experimental hepatitis C treatment

Bristol-Myers Missing Hep C Data Raises Red Flags, May Boost Gilead, Idenix

Editor's pick
The Street
8 May 2012
New & experimental hepatitis C treatment

GS-7977 with interferon/ribavirin cures most treatment-naive hepatitis C patients in 12 weeks

News
30 April 2012
Pharmaceutical industry

Gilead Sciences 1Q profit down on Pharmasset costs

Editor's pick
CBS News
27 April 2012
New & experimental hepatitis C treatment

US: do not mix Merck hepatitis pill with HIV drugs

Editor's pick
Reuters
27 April 2012
New & experimental hepatitis C treatment

NICE publishes final guidance on two new drugs for chronic hepatitis C

Editor's pick
NICE press release
25 April 2012
New & experimental hepatitis C treatment

Telaprevir May Cause Severe Cutaneous Eruptions

Editor's pick
Medscape (requires free registration)
24 April 2012
New & experimental hepatitis C treatment

Abbott interferon-free HCV combinations show early promise in untreated patients

News
23 April 2012
New & experimental hepatitis C treatment

Grading Hep C Stocks Exiting EASL - The future of hepatitis C therapy belongs to interferon-free regimens

Editor's pick
The Street
23 April 2012
New & experimental hepatitis C treatment

Boceprevir a useful option for patients who did not respond to earlier course of hepatitis C therapy

News
23 April 2012
New & experimental hepatitis C treatment

Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C

Editor's pick
Achillion (press release)
23 April 2012
New & experimental hepatitis C treatment

Achillion Clarifies End of Treatment Data From Phase 2a Trial With ACH-1625 Based Regimen in Hepatitis C

Editor's pick
Achillion (press release)
23 April 2012
New & experimental hepatitis C treatment

Adding TMC435 boosts response for difficult-to-treat hepatitis C patients

News
23 April 2012
New & experimental hepatitis C treatment

Hepatitis C drug alisporivir is effective, but pancreatitis a concern

News
23 April 2012
Hepatitis C treatment side-effects

Telaprevir and boceprevir show high rate of serious side-effects in hepatitis C patients with urgent need of treatment

News
20 April 2012
New & experimental hepatitis C treatment

Hepatitis C meds GS-7977, daclatasvir and asunaprevir look good in interferon-free combos

News
20 April 2012
New & experimental hepatitis C treatment

J&J Open to Expanding Hepatitis C Collaboration With Vertex

Editor's pick
HCV New Drugs Research
20 April 2012
New & experimental hepatitis C treatment

Interferon-lambda as effective as alpha but with much better safety profile in hepatitis C

News
20 April 2012
New & experimental hepatitis C treatment

Pancreatitis Forces Halt to HCV Drug Trial

Editor's pick
MedPage Today
20 April 2012